Hopantomide in pediatric neurological practice: outlooks
Hopantomide® is a drug containing calcium salt of hopantenic acid. The drug is registered and produced in Russia (Usolye-Siberian Chemical Pharmaceutical Factory) with the use of own raw materials and goes through a full production cycle, which guarantees quality control at every stage. Hopantomide...
Saved in:
Main Author: | O. A. Pylaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-02-01
|
Series: | Русский журнал детской неврологии |
Subjects: | |
Online Access: | https://rjdn.abvpress.ru/jour/article/view/351 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
by: Williams A, et al.
Published: (2016-02-01) -
The Historical Evolution of the Medicalization of Children's Attention Deficit Hyperactivity Disorder
by: Weiyu LI, et al.
Published: (2025-02-01) -
Cognitive and behavioral performance in children with epilepsy with myoclonic–atonic seizures
by: Ericka Olívia Rodrigues Samoiloff, et al.
Published: (2025-07-01) -
Screening for attention deficit and hyperactivity disorder, autism spectrum disorder, and developmental delay in Taiwanese aboriginal preschool children
by: Chan HL, et al.
Published: (2016-10-01) -
THE SYSTEM OF COMPLEX REHABILITATION OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: NOVEL APPROACH TOWARDS OBSERVATION AND TREATMENT
by: O. R. Nogovitsina, et al.
Published: (2012-01-01)